Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach
Torki A. Zughaibi, Mohd Suhail, Mohammad Tarique, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12455-12455
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Astaxanthin-loaded PLGA nanoparticles inhibit survival of MKN-45 gastric cancer cell line by modulating JAK2/STAT3/mTOR/PI3K pathway
Mohammad Hossein YektaKooshali, Mahdieh SobhZahedi, Seyed Mohammad Taghi Razavi Tousi, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer
Naoshad Muhammad, Darksha Usmani, Mohammad Tarique, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2209-2209
Open Access | Times Cited: 63
The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review
E Ferrari, Saverio Bettuzzi, Valeria Naponelli
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6075-6075
Open Access | Times Cited: 61
Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
Divya Ajmeera, Rajanna Ajumeera
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 148-175
Open Access | Times Cited: 31
Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer Treatment
Iftikhar Ahmad, Mehboob Hoque, Syed Sahajada Mahafujul Alam, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6651-6651
Open Access | Times Cited: 31
Flavonoids nanostructures promising therapeutic efficiencies in colorectal cancer
Sepideh Hassani, Hossein Maghsoudi, Fahimeh Fattahi, et al.
International Journal of Biological Macromolecules (2023) Vol. 241, pp. 124508-124508
Closed Access | Times Cited: 25
Tumor microenvironment remodeling in oral cancer: Application of plant derived-natural products and nanomaterials
Hendrik Setia Budi, Bagher Farhood
Environmental Research (2023) Vol. 233, pp. 116432-116432
Closed Access | Times Cited: 22
Exploring Natural Products as Radioprotective Agents for Cancer Therapy: Mechanisms, Challenges, and Opportunities
Yi Zhang, Ying Huang, Zheng Li, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3585-3585
Open Access | Times Cited: 21
Synergistic therapeutic strategies and engineered nanoparticles for anti-vascular endothelial growth factor therapy in cancer
Asmaa F. Khafaga, Mohamed M. S. Gaballa, Reham Karam, et al.
Life Sciences (2024) Vol. 341, pp. 122499-122499
Closed Access | Times Cited: 11
Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation
Olga Golubnitschaja, Andrea Kapinová, Nafiseh Sargheini, et al.
The EPMA Journal (2024) Vol. 15, Iss. 2, pp. 163-205
Open Access | Times Cited: 11
Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions
Megh Pravin Vithalkar, Shaili Pradhan, K. Sandra, et al.
Cell Biochemistry and Biophysics (2025)
Open Access
Exploring the therapeutic potential of quercetin in cancer treatment: Targeting long non-coding RNAs
Farhad Sheikhnia, Ahmad Fazilat, Vahid Rashidi, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155374-155374
Closed Access | Times Cited: 6
Isorhamnetin: what is the in vitro evidence for its antitumor potential and beyond?
Jiaming Lei, Jianbao Yang, Cuiyu Bao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Anti-tumor Effects of Polyphenols via Targeting Cancer Driving Signaling Pathways: A Review
Kareena Moar, Somu Yadav, Anuja Pant, et al.
Indian Journal of Clinical Biochemistry (2024) Vol. 39, Iss. 4, pp. 470-488
Closed Access | Times Cited: 5
Nanotechnology-driven EGCG: bridging antioxidant and therapeutic roles in metabolic and cancer pathways
Zahra Esmaeili, Parisa Shavali Gilani, Masood Khosravani, et al.
Nanomedicine (2025), pp. 1-16
Closed Access
A novel approach to glioblastoma multiforme treatment using modulation of key pathways by naturally occurring small molecules
Amir R. Afshari, Mehdi Sanati, Samaneh Aminyavari, et al.
Inflammopharmacology (2025)
Closed Access
Interplay Between Traditional and Scientific Knowledge: Phytoconstituents and Their Roles in Lung and Colorectal Cancer Signaling Pathways
I. Imtiaz, Janet Schloss, Andrea Bugarc̀ić
Biomolecules (2025) Vol. 15, Iss. 3, pp. 380-380
Open Access
Protective effects of natural products against myocardial ischemia/reperfusion: Mitochondria-targeted therapeutics
Xin Su, Mingyang Zhou, Yingjian Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112893-112893
Open Access | Times Cited: 22
Phenolic Acids-Mediated Regulation of Molecular Targets in Ovarian Cancer: Current Understanding and Future Perspectives
Nazia Nazam, Nasimudeen R. Jabir, Iftikhar Ahmad, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 274-274
Open Access | Times Cited: 14
PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection
V. S. Lekshmi, Kumari Asha, Melvin Sanicas, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 14
Analysis of some flavonoids for inhibitory mechanism against cancer target phosphatidylinositol 3-kinase (PI3K) using computational tool
Mohd Suhail, Wejdan M. AlZahrani, Shazi Shakil, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathway
Preeti Sharma, Mohammad Ahmed Khan, Abul Kalam Najmi, et al.
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 20
Anticancer potential of gold nanoparticles (AuNPs) using a battery of in vitro tests
Nouf Omar Alafaleq, Alya Alomari, Mohd Shahnawaz Khan, et al.
Nanotechnology Reviews (2022) Vol. 11, Iss. 1, pp. 3292-3304
Open Access | Times Cited: 18
BFNB Enhances Hair Growth in C57BL/6 Mice through the Induction of EGF and FGF7 Factors and the PI3K-AKT-β-Catenin Pathway
Salvador Pérez-Mora, Juan Ocampo-López, María del Consuelo Gómez-García, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12110-12110
Open Access | Times Cited: 11
Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics
Deena Elsori, Pratibha Pandey, Seema Ramniwas, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top